Measure and interpretation of CF gene therapy trial results.
Alton
E
E
Geddes
D
D
Gill
D
D
Greening
A
A
Higgins
C
C
Hyde
S
S
Innes
J A
JA
Porteous
D
D
Stern
M
M
D002712:Chlorides / Q000378:metabolism; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000628:therapy*; D004134:Dimyristoylphosphatidylcholine / Q000031:analogs & derivatives / Q000494:pharmacology; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D008081:Liposomes / Q000235:genetics; D009297:Nasal Mucosa / Q000378:metabolism; D012107:Research Design
C108836:1,2-dimyristoyl-sn-glycero-3-ethylphosphocholine; D002712:Chlorides; D008081:Liposomes; D004134:Dimyristoylphosphatidylcholine